Great Basin heads to FDA with staph test; Illumina seals the deal for GenoLogics;

> Great Basin Scientific ($GBSN) submitted its staph ID/R blood culture test to the FDA for 510(k) clearance. Statement

> Illumina ($ILMN) closed its previously-announced deal for lab information management company GenoLogics. Release

> German diagnostic outfit Analytik Jena snagged a CE mark for its hepatitis D test. More

> Veracyte ($VCYT) and the Pulmonary Fibrosis Foundation are teaming up for a U.S. patient survey to get individuals' feedback on being diagnosed with lung diseases. Statement

> Springdale, AK-based NOWDiagnostics snatched up Canada's ZBx to gain ground in rapid, point-of-care diagnostics. Release

And Finally… A New Jersey federal judge ordered a Swiss pregnancy test maker to run corrective ads in U.S. magazines after finding that the company misled consumers about its product. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.